Assessment of levels of the tumor markers HE4 and CA125 considering staging, grading and histological types of endometrial cancer

被引:7
作者
Abdalla, Nabil [1 ]
Piorkowski, Robert [1 ]
Stanirowski, Pawel [1 ]
Slomka, Anna [1 ]
Cendrowski, Krzysztof [1 ]
Sawicki, Wlodzimierz [1 ]
机构
[1] Med Univ Warsaw, Fac Med 2, Chair & Clin Obstet Gynecol & Oncol, Kondratowicza 8, PL-03242 Warsaw, Poland
来源
MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY | 2016年 / 15卷 / 03期
关键词
endometrial cancer; CA125; HE4; staging; grading;
D O I
10.5114/pm.2016.63059
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Aim of the study was to assess statistical differences of serum levels of HE4 and CA125 between certain endometrial cancer stages, grading and histological types. Material and methods: A retrospective study of 52 patients admitted to our clinic for a surgical operation because of endometrial cancer was performed. HE4 and CA125 were measured for each patient. The staging was done according to FIGO. The statistical difference of serum levels of tumor markers was analyzed considering different stages, grading and histological types. Results: Most of the patients (92.31%) were post-menopausal. Serum levels of tumor markers were significantly higher among patients with stage IB-IIIC than stage IA, among patients with stages II-III than stage I and among patients with stage IIIC than stage IA-IIIB. Only HE4 was significantly higher among patients with stage IB than stage IA and among patients with grading G2 and G3 than those with G1. Only CA125 was significantly higher among patients with stage IIIA and IIIB than those with stages I and II. There was no statistically significant difference in level of either tumor marker in differentiation of endometrioid from other histological endometrial cancer. Conclusions: Both tumor markers HE4 and CA125 can be useful additional tools for pre-surgical differentiation between different stages of endometrial cancer. HE4 can predict advanced histological grades. Neither HE4 nor CA125 can differentiate endometrioid from other histological types of endometrial cancer.
引用
收藏
页码:133 / 137
页数:5
相关论文
共 31 条
  • [1] Transvaginal/transrectal ultrasound for preoperative identification of high-risk cases in well- or moderately differentiated endometrioid carcinoma
    Alcazar, J. L.
    Pineda, L.
    Caparros, M.
    Utrilla-Layna, J.
    Juez, L.
    Minguez, J. A.
    Jurado, M.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2016, 47 (03) : 374 - 379
  • [2] Endometrial cancer
    Amant, F
    Moerman, P
    Neven, P
    Timmerman, D
    Van Limbergen, E
    Vergote, I
    [J]. LANCET, 2005, 366 (9484) : 491 - 505
  • [3] The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program
    Angioli, Roberto
    Capriglione, Stella
    Scaletta, Giuseppe
    Aloisi, Alessia
    Miranda, Andrea
    Nardone, Carlo De Cicco
    Terranova, Corrado
    Plotti, Francesco
    [J]. TUMOR BIOLOGY, 2016, 37 (04) : 4973 - 4978
  • [4] The role of novel biomarker HE4 in endometrial cancer: a case control prospective study
    Angioli, Roberto
    Plotti, Francesco
    Capriglione, Stella
    Montera, Roberto
    Damiani, Patrizio
    Ricciardi, Roberto
    Aloisi, Alessia
    Luvero, Daniela
    Cafa, Ester Valentina
    Dugo, Nella
    Angelucci, Michela
    Benedetti-Panici, Pierluigi
    [J]. TUMOR BIOLOGY, 2013, 34 (01) : 571 - 576
  • [5] HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET)
    Antonsen, Sofie L.
    Hogdall, Estrid
    Christensen, Ib J.
    Lydolph, Magnus
    Tabor, Ann
    Jakobsen, Annika Loft
    Fago-Olsen, Carsten L.
    Andersen, Erik S.
    Jochumsen, Kirsten
    Hogdall, Claus
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2013, 92 (11) : 1313 - 1322
  • [6] A RADIOIMMUNOASSAY USING A MONOCLONAL-ANTIBODY TO MONITOR THE COURSE OF EPITHELIAL OVARIAN-CANCER
    BAST, RC
    KLUG, TL
    STJOHN, E
    JENISON, E
    NILOFF, JM
    LAZARUS, H
    BERKOWITZ, RS
    LEAVITT, T
    GRIFFITHS, CT
    PARKER, L
    ZURAWSKI, VR
    KNAPP, RC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (15) : 883 - 887
  • [7] Diagnostic value of serum HE4 in endometrial cancer: a meta-analysis
    Bie, Yachun
    Zhang, Zhenyu
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [8] Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients
    Bignotti, E.
    Ragnoli, M.
    Zanotti, L.
    Calza, S.
    Falchetti, M.
    Lonardi, S.
    Bergamelli, S.
    Bandiera, E.
    Tassi, R. A.
    Romani, C.
    Todeschini, P.
    Odicino, F. E.
    Facchetti, F.
    Pecorelli, S.
    Ravaggi, A.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 104 (09) : 1418 - 1425
  • [9] Human epididymis protein 4 reference limits and natural variation in a Nordic reference population
    Bolstad, Nils
    Oijordsbakken, Miriam
    Nustad, Kjell
    Bjerner, Johan
    [J]. TUMOR BIOLOGY, 2012, 33 (01) : 141 - 148
  • [10] Serum HE4 as a prognostic marker in endometrial cancer - A population based study
    Brennan, Donal. J.
    Hackethal, Andreas
    Metcalf, Alex M.
    Coward, Jermaine
    Ferguson, Kaltin
    Oehler, Martin K.
    Quinn, Michael A.
    Janda, Monika
    Leung, Yee
    Freemantle, Michael
    Webb, Penelope M.
    Spurdle, Amanda B.
    Obermair, Andreas
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 132 (01) : 159 - 165